Company intelligence / Profile preview
Hoth Therapeutics
New York, New York, USA
- Ownership
- Public · HOTH
- Development stage
- Preclinical
01
Overview
Hoth Therapeutics has reported positive initial data in a Phase IIa clinical trial for one of its programs. Its lead Alzheimer's candidate HT‑ALZ demonstrated significant cognitive and behavioral benefits in preclinical models. The company’s cancer/immunology program HT-KIT has advanced through key preclinical safety studies with plans to enter first-in-human trials. Overall pipeline includes both clinical and late-preclinical assets addressing high unmet needs in neurology, oncology/allergy/inflammation, and dermatology.
- Therapeutic areas
- DermatologyOncologyImmunologyNeurology
- Modalities
- Antisense oligonucleotides (ASO)Small molecules (e.g., NK‑1 receptor antagonist)Proprietary drug formulations
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
Washington University School of Medicine collaboration on Alzheimer’s research/NIH grant applicationpartnerships with OnTargetx R&D Inc. & ITR Laboratories for preclinical studiescollaborations with academic institutions and contract manufacturing organizations are part of their model.
04
Financials
- Market cap
- $10.6M
- Total revenue
- $0
- Enterprise value
- $2.7M
Beyond the preview
Go deeper on Hoth Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hoth Therapeutics.